Documents

263 documents

Enter search criteria

Fill in keyword(s) to narrow your search.

Assessment report Chia seed, applicant Bravo Foods B.V.

A report on the assessment of chia seed by the company Bravo Foods B.V. for substantial equivalence to chia seed, which has...

Report | 19-06-2017

MEB 47: Assessment criteria for combination packages

The Medicines Evaluation Board (MEB) has described the terms and conditions which are to be used to assess applications for...

Directive | 15-06-2017

Assessment report DHA-rich algal oil, applicant Changsha Sunnycare Inc.

A report on the assessment of DHA-rich algal oil by the company Changsha Sunnycare Inc for substantial equivalence to DHA-rich...

Report | 14-06-2017

MEB Annual Report 2016: Appendices

Annual report | 01-06-2017

Assessment report chondroitine sulphate, applicant Gnosis S.p.A.

A report on the initial assessment of chondroitine sulphate by the company Gnosis S.p.A.

Report | 23-05-2017

Empty SPC template – QRD 8.1 (MRP/DCP/national)

Form | 15-05-2017

Influenza strains: Dutch translation of active substances 2017/2018

The Medicines Evaluation Board (MEB) has confirmed the Dutch translation for the active substances for influenza strains for...

Publication | 08-05-2017

Assessment report Chia seed, applicant Tradin Organic Agriculture B.V.

A report on the assessment of chia seed by the company Tradin Organic Agriculture B.V. for substantial equivalence to chia...

Report | 14-04-2017

Overview of approved compassionate use programmes

The MEB can give permission for bringing a medicinal product on the market that has not (yet) been granted a marketing...

Publication | 10-04-2017

MEB 48: National informed consent application

An Article 10c 'Informed Consent' application (article 10c of Directive 2001/83/EC)  is an application for marketing...

Directive | 27-03-2017